Circio Holding ASA 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Cha Biotech Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Chongqing Yao Pharmaceutical Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Crescent Biopharma, Inc. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Beijing Aosaikang Pharmaceutical Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Nippon Shinyaku Co., Ltd. 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Lakefront Biotherapeutics 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

Apertura Gene Therapy LLC 2026 BD opportunity scan covering pipeline assets, ownership, stage, transaction precedents, financial signals, IP risk and outreach priorities.

NCT07661537 clinical trial report covering SHR-3079, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661797 clinical trial report covering LNF2105, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07660055 clinical trial report covering [177Lu]Lu-zolbetuximab, Phase 1, endpoints, sponsor, geography, readout timing and development white space.

NCT07661095 clinical trial report covering CRD-3874, Phase 1, endpoints, sponsor, geography, readout timing and development white space.